Articles | Open Access | https://doi.org/10.55640/

CONGENITAL HEART DEFECTS IN CHILDREN (LITERATURE REVIEW)

Odilova Shakhzoda Rustamovna,Tilavova Aziza Komilovna , Samarkand State Medical University, Samarkand, Uzbekistan.

Abstract

Congenital heart defects (CHDs) represent one of the most significant challenges in pediatric cardiology and cardiovascular surgery worldwide [1]. According to the World Health Organization (WHO), the incidence of CHDs ranges from 8 to 12 per 1,000 live births [2]. In the structure of childhood mortality, cardiovascular pathology remains one of the leading causes, with CHDs accounting for 30–45% of all mortality associated with congenital developmental anomalies [3].

Keywords

References

Gurevich MA, Komissarova MS, Salikhova AO. Congenital heart defects in newborns: current issues and solutions. Pediatrics. 2019;98(7):15-21.

World Health Organization. Congenital anomalies. WHO fact sheets. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies (accessed 10.02.2025).

Kalinovsky GM, Sitnikov VG. Congenital heart defects in the structure of congenital anomalies in children. Issues of Modern Pediatrics. 2020;19(4):29-34.

Kolesov VI, Bockeria LA, Fadeev ME. Problems of diagnosis and surgical treatment of congenital heart defects in children in Russia. Russian Journal of Cardiology. 2021;26(5):7-15.

Kharchenko SL, Shkolnik EL, Efimova KA. Clinical and diagnostic characteristics of congenital heart defects in young children. Pediatrics named after G.N. Speransky. 2020;99(2):26-32.

Wilson NR, Devereux RB, Narula J. Genetics of Congenital Heart Disease: A Clinical Primer. J Am Coll Cardiol. 2018;72(19):2391-2405.

Nagornaya IF, Rodionova IA, Baskakova GA. Genetic aspects of congenital heart defects in children. Medical Genetics. 2019;18(3):43-49.

Zidere V, Miller O. Prenatal echocardiography: past, present and future. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):193-197.

Funai T, Sato M, Nakamoto S, et al. Delayed presentation of congenital heart disease: current aspects of diagnosis and management. Pediatr Cardiol. 2019;40(8):1677-1685.

Deng J, Feng Y, Cao Y, et al. Fetal echocardiography in the diagnosis of congenital heart disease: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(18):e25513.

Kiselev VV, Zubarev PV, Mikhailova YG. Perinatal diagnosis of congenital heart defects: experience of a multidisciplinary center. Obstetrics and Gynecology. 2020;8(3):56-61.

Makarova VG, Kiryukhina EV. Modern ultrasound diagnostics of congenital heart defects in children: a literature review. Medical Imaging. 2021;25(2):41-49.

Gittenberger-de Groot AC, Jongbloed MRM, Galis E, et al. Morphological classification of congenital heart defects: the ongoing quest for clinically meaningful classification. Anatol J Cardiol. 2019;22(2):56-68.

Serov RA, Karaskin VM, Chumakov SV. Surgical tactics for the most common CHDs in children: literature review and experience of one center. Cardiology. 2021;61(1):18-27.

Ewer AK, Gardiner HM, Furmston AT, et al. Pulse oximetry screening and critical congenital heart disease. Lancet. 2021;398(10305):

Джураев Ж. Д., Абдукадирова Ш. Б., Мамаризаев И. К. HISTORICAL, CLINICAL, LABORATORY AND INSTRUMENTAL CHARACTERISTICS OF HEMORRHAGIC DISEASE OF NEWBORNS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2024. – Т. 5. – №. 2.

Мамаризаев И. К. FEATURES OF THE COURSE, MORPHO-FUNCTIONAL AND CLINICAL-INSTRUMENTAL INDICATORS OF COMMUNITY-ACQUIRED PNEUMONIA WITH MYOCARDITIS IN CHILDREN //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2024. – Т. 5. – №. 2.

Мамаризаев И. К. ОПТИМИЗАЦИЯ ЛЕЧЕНИЯ АТОПИЧЕСКОГО ДЕРМАТИТА У ДЕТЕЙ //ILM FAN XABARNOMASI. – 2024. – Т. 1. – №. 2. – С. 320-325.

Komilzhonovich M. I. OPTIMIZATION OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN //International journal of scientific researchers (IJSR) INDEXING. – 2024. – Т. 5. – №. 2. – С. 642-646.

Мамаризаев И. К., Абдукадирова Ш. Б., Джураев Ж. Д. THE ROLE OF THE HEMOSTATIC SYSTEM IN THE DEVELOPMENT OF ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN AGAINST THE BACKGROUND OF MYOCARDITIS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2023. – Т. 4. – №. 5.

Каминский ВВ, Фишман МА. Критические врожденные пороки сердца: современные аспекты и перспективы лечения. Российский педиатрический журнал. 2022;25(5):12-19.

Franklin O, Burch M, Manning N, Sleap V, Macartney F. Prenatal diagnosis of congenital heart disease improves survival and reduces morbidity. Heart. 2018;104(9):673-679.

Sammour I, Sari T, Birk E, Zucker N, Rein AJ. Long-term outcome and risk factors for mortality after pediatric congenital heart surgery: a 15-year experience. Cardiol Young. 2019;29(4):489-498.

Семенова ЮП, Мамаев ДВ, Кузьмина НФ. Анализ коморбидной патологии у детей с врожденными пороками сердца. Педиатрия. 2021;100(2):64-69.

Габуния АИ, Турецкая АВ, Маторина НБ. Современные тенденции в диагностике и лечении врожденных пороков сердца: обзор. Российский вестник перинатологии и педиатрии. 2021;66(5):38-49.

Webb GD, Smallhorn JF, Therrien J. Congenital Heart Disease. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019. p. 1683-1720.

Brown KL, Crowe S, Franklin RCG, et al. The impact of multidisciplinary care on outcomes in congenital heart disease. Eur J Cardiothorac Surg. 2020;58(2):241-248.

Hornberger LK, Sanders SP, Rein AJ, et al. Revised guidelines for the performance of fetal echocardiography. Ultrasound Obstet Gynecol. 2019;54(2):177-185.

Sifrim A, Hitz MP, Wilsdon A, et al. Interpreting secondary genetic findings in the pediatric population: congenital heart disease as a model. Genet Med. 2018;20(9):1048-1056.

Fogel MA, Jacobs ML, Norwood WI, et al. Cardiac MRI and CT: evaluation of congenital heart disease in children and adolescents. Circulation. 2018;137(10):1045-1060.

Mertens L, Helbing W, Sieverding L, et al. Expert consensus statements on the management of medication in pediatric heart failure. Cardiol Young. 2020;30(10):1430-1440.

Rosenthal D, Chrisant M, Edens E, Mahony L. The pediatric cardiomyopathy and heart failure: general considerations and current therapies. Prog Pediatr Cardiol. 2019;53:101-108.

Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2020;6(10):CD004213.

Кулаков ВВ, Летягина АВ, Степанова СВ. Эндоваскулярные методы лечения врожденных пороков сердца: клинический опыт одного центра. Кардиология. 2019;59(5):63-69.

McElhinney DB, Hornberger LK. Management of congenital heart disease in the newborn. Lancet. 2019;393(10173):161-174.

Kuijpers JM, Koolbergen DR, Groenink M, et al. Long-term outcomes of adult survivors of congenital heart disease. Eur Heart J. 2020;41(22):4161-4170.

Drzewiecka B, Królak-Olejnik B, Kalisiak B. The importance of folic acid in the prevention of congenital heart defects: a review. Dev Period Med. 2019;23(3):232-239.

Андреева ЕН, Ларина ВН, Сырейщикова ТЮ. Пренатальная эхокардиография и её значение в диагностике тяжёлых ВПС. Российский вестник акушера-гинеколога. 2021;21(6):44-50.

McBrien A, Kenny D. Multidisciplinary team management in congenital heart disease. Heart. 2020;106(9):681-686.

Исаева ДП, Дроздова ЮС, Бабенко ПВ. Психологическая адаптация детей с врожденными пороками сердца после оперативного лечения. Вопросы детской психологии. 2022;15(3):72-78.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

CONGENITAL HEART DEFECTS IN CHILDREN (LITERATURE REVIEW). (2025). International Journal of Medical Sciences, 5(02), 276-285. https://doi.org/10.55640/